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Summary
We report a case of a man presenting with a cervical malignant
teratoma and a chondrosarcomatous rib metastasis. He was
alive and free of recurrence five years and 10 months (= 70
months) after resection of the primary mass, followed by che-
motherapy and subsequent resection of the rib tumor. This is
the 35th patient reported in the literature and the first descrip-
tion in which an 'adjuvant' or primary chemotherapy was used.
Previous patients with a cervical malignant teratoma, reported
after lethal outcome, had survivals of one to 22 months (me-
dian nine months). In all patients with a preoperative clinical
impression of an aggressive, differentiated or undifferentiated
malignancy, the definite diagnosis of teratoma could only be
made histologically. By analogy to germ cell tumors, the prog-
nosis of malignant teratoma might be improved if complete
excision is combined with new, adjuvant chemotherapy proto-
cols for germ cell tumors. Lessons learned from this case are
placed in the context of germ cell tumors in general and of
non-gonadal malignant teratomas in particular.
Key words: chemotherapy, cervical, germ cell tumor, prognosis,
surgery, teratoma
Case report
a) History and clinical findings
A white, 33-year-old man was referred because of a mass
on the anterior left side of the neck. He had first felt the
painless nodule a month previously and was aware that
it had grown after this date. There were no symptoms of
mechanical obstruction. He had no previous history of
any operation of or irradiation to his neck. On clinical
examination, he was in a good general condition, with-
out any distress. A firm, elastic, 6 x 5cm tumor mass
was situated in front of the medial rim of the left sterno-
cleidomastoid muscle and extended into the left thoracic
aperture. It was fixed to the underlying structures but
not to the skin. There were no palpable lymph nodes.
Laryngoscopy was normal.
b) Preoperative investigations
A chest X-ray showed a focal swelling of the 10th left rib
due to a poorly delineated osteolytic lesion, compatible
with an enchondroma. A computerized tomography of
the neck (Figure 1) after contrast injection showed an
inhomogeneous tumor mass ( 8 x 4 cm). This was lateral
to the thyroid with compression of the left thyroid lobe,
of the left side of the trachea and the left neck vessels and
with possible infiltration of the jugular vein. The density
of the mass was 11-73 HU. Routine blood and urine
examinations were normal. Thyroid studies revealed
euthyroidism with normal values of thyroxine, triiodo-
thyronine, thyrotropine. The thyroid uptake (two hours,
123-1, 7.4 MBq) was 9%. The 1:1 thyroid scan (123-1 and
99mTc-Methoxyisobutylisonitrile [4] (MIBI, Cardiolite®
Figure I. Transverse CT section of the neck after intravenous injection
of contrast media: note the large, inhomogeneous tumor mass in a left
supraclavicular location, measuring 8 x 4 cm in diameter. The tumor
density was 11-73 HU. Infiltration of the left internal jugular vein was
suspected. Compression of the left tracheal wall, displacement of the
left thyroid lobe, of the left vessels and of the sternocleidomastoid
muscle were noted.
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Figure 2. Thyroid scan, performed two hours after oral administration
of 7.4 MBq 123-1 (Polyscan), showing a homogeneous activity distri-
bution within a slim, 20 g gland. The lateral margin of the left lobe is
compressed by a cold nodule of 6 x 5 cm diameter.
Dupont, USA): 185 MBq) showed homogeneous activity
distribution in a slim, 20 g gland (Figure 2). The lateral
margin of the left lobe was impressed by a cold nodule of
6 x 5 cm diameter. Two-dimensional ultrasonography
showed a well delineated nodule of inhomogeneous
echostructure lateral to and compressing the left thyroid
lobe. Several small cystic areas, a few hyperdense foci,
but no calcium deposits were noted. Fine needle aspira-
tion biopsy produced only cystic fluid without cellular
elements suspicious of malignancy. Cytology of a second
aspiration showed, besides psammous bodies, some
papillary components containing medium sized cells
with rough nuclei, clear nucleoli and even some nucleic
vacuoles. Based on fine needle biopsy, a papillary carci-
noma of the thyroid was initially suspected.
c) Neck surgery
A left cervicotomy with total removal of a large, supra-
and infraclavicular tumor measuring 7 x 5 cm in diame-
ter, with a clear margin of healthy tissue around it, was
performed on 1 July 1992. The tumor capsule was not
incised or ruptured. There was no direct link to the
thyroid. As the tumor was firmly adherent to the left
jugular vein, the vein was resected en bloc with the
tumor. The postoperative course was uncomplicated.
d) Histology
Pathologic macroscopic examination revealed a solitary
tumor with a thin, but intact capsule of fibrous tissue.
Cross sections revealed multiple haemorrhagic and se-
rous cysts (±50% of the volume) being separated by
yellow-whitish solid areas. Microscopically, the cystic
spaces were lined by columnar epithelia bordering regu-
lar serous salivary gland parenchyma (approximately
Figure 3 Histological section: Cyst lined by columnar epithelium
bordering regular serous salivary gland parenchyma with loose lympho-
histiocytic infiltrates (H & E, original magnification x 87).
Figure 4. Histological duct structures, which may represent remnants
of mature salivary glands. A solitary concentric focus of squamous
epithelial metaplasia is present within abundant irregularly arranged
fibrous stroma (H & E, original magnification x 87).
10% of the total volume) with patchy lymphocytic infil-
trates (Figure 3). Thyroid parenchyma was not seen. The
composition of the remainder of the tissue volume was
heterogeneous. Intermingled with mature duct structures
which might represent remnants of salivary gland ducts,
concentric foci of squamous epithelial metaplasia in
irregularly arranged loose fibrous stroma were present
(Figure 4). Other mesenchymal counterparts (±30% of
the volume) were made up of mature smooth muscle, but
there was also hypercellular hyaline cartilage with slight
irregularities in cellular size and shape, which suggested
a grade 1 chondrosarcoma (Figure 5). In addition, tubu-
lar epithelial structures resembling embryonal carcinoma
with occasional yolk sack-like projections were frequent.
A few true rosettes, typical of neuroepithelial differentia-
tion were present [6, 7, 9] (Figure 6). They were growing
in an immature mesenchymal stroma, also displaying
cytomorphologic atypia and mitotic activity (Figure 6),
while additional features of so-called unfavorable histol-
ogy such as rhabdomyosarcoma were absent. Scattered
haemorrhagic necrosis was present in the malignant
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Figure 5. Histological section: Hypercellular mature hyaline cartilage
with variation in cellular size and shape is suggestive of low-grade
chondrosarcoma and is a frequent component of the mesenchymal
counterpart of the tumor (H & E, original magnification x 175).
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Figure 6. Histological section: Malignant epithelial counterpart of the
tumor resembling embryonal carcinoma with yolk sack-like structures
(arrow) and true rosettes (arrowhead) typical for neuroepithelial differ-
entiation. The immature stroma displays mitotic activity (H & E,
original magnification x 175).
components. A minimal local invasion of the intact
fibrous capsule and of the sinuses of a small neighboring
lymph node was seen. The conclusion was that this was
a malignant teratoma (or teratocarcinoma) with compo-
nents of both germ cell and of differentiated mesenchy-
mal tumor. According to the WHO classification, this
entity with two tumor components is distinct from an
extragonadal germ cell tumor of mixed type, that lacks
differentiated (e.g., non-germ cell) tissue.
e) Postoperative investigations
In order to differentiate between a primary or a meta-
static teratoma to the neck, further diagnostic procedures
were performed. The laboratory findings of: alphafoeto-
protein, lactate dehydrogenase, human chorionic gonado-
tropin, human thyreoglobuline were normal. A clinical
examination by an urologist was normal. A computer-
ized tomography of the pelvis and of the abdomen and an
ultrasonography of the testicles showed no pathologic
tumor masses. A computerized tomography of the thorax
again showed the known swelling of the 10th lateral left
rib, compatible with an enchondroma. A bone scintigra-
phy with 99mTc-MDP showed no sign of skeletal metas-
tases and in particular, the scintigraphic findings within
the swollen 10th left rib were normal. During the next
four months, the patient refused surgical resection of the
rib mass. Finally, on 6 November 1992, a partial excision
of the 10th left rib with total tumor resection was
performed. Histology revealed a grade 1-2 chondro-
sarcoma, which probably represented a rib metastasis
of the known malignant teratoma, although another
primary tumor could not be formally excluded.
f) Adjuvant chemotherapy and outcome
Immediately after neck surgery, the medical intention
was to treat with adjuvant chemotherapy. This is why,
prior to the surgical rib resection, which was initially
refused by the patient, two cycles of classical BEP
chemotherapy (bleomycin: absolute doses 30 mg days 1,
8 and 15; etoposide: 100 mg/m2 over one hour from day
1-5 included, and cisplatin: 20 mg/m2 intravenously as
a 30 minutes infusion from day 1-5 included [5]) were
administered (September to October 1992). The chemo-
therapy was intended to be an adjuvant treatment,
though the subsequent finding of a rib chondrosarcoma
led to the conclusion that chemotherapy had instead
been given for metastatic disease. Chemotherapy was
well tolerated. Since then, the patient has remained free
of symptoms and in good condition for more than five
years (five years and 10 months at the time of this report)
since resection of the primary neck tumor. Regular clin-
ical, radiologic and blood serum tests have not indicated
any sign of tumor recurrence.
We have given two adjuvant cycles of chemotherapy
according to our policy in patients with testicular stage I
germ cell tumors with elements of embryonal histology,
where a relapse rate of 30% is to be expected. This policy
was shown to reduce the relapse rate from 30% to 5% in
this group of patients [44]. Since the rib lesion was scinti-
graphically negative and initially judged to be benign,
additional chemotherapy was not thought to be neces-
sary. Only after excision did it become clear that it was
more likely a metastasis, possibly cleared of embryonal
elements due to previous chemotherapy. Also the possi-
bility of a synchronous multifocal teratocarcinoma can
formally not be ruled out.
Discussion
a) Classification
Teratomas are tumors composed of several different tis-
sues foreign to the anatomic site of origin in which they
arise. They consist of all three germ layers: ectoderm,
mesoderm and endoderm. A fine capsule is the rule.
Microscopic examination reveals a variety of tissues
Table I. Adult cervical malignant teratoma (locations at the skull base and along the cervical spine omitted): Chronological literature review of 24 published patients, including ours.
Publication
Reference
1 Uirje, 1908 [11]
2 Waechter, 1909 [12]
3 Fritzsche, 1920 [12]
4 Buckwalter, 1954(13)
5 Kemp, 1967 [19]
6 Hajdu, 1967 [21]
7 Pilheu, 1969 [22]
8O'Higgins, 1975 [23]
9 Colton, 1978 [24]
lOKimler, 1978(25]
11 Dhellemcsl, 1979 [27]
12Dhellemesll, 1979 [27]
13 Murao, 1979 [28]
14 Przystasz, 1979 [2]
15Trotoux, 1979 [29]
16Tobey, 1980 [30]
17Ceriani, 1984 [31]
IS Kicr, 1985(32]
19 Buckley, 1986 [33]
20 Mochizuki. 1986 [34]
21 Jordan, 1988(36]
22 Kahle. 1990 [37]
23 Cain. 1991 [38]
24Als, 1998 [this public]
Country
CH
Germany
CH
USA, w
Autralia, w
USA, w
Argentine
Irak
USA
USA, b
France
France
Japan
Poland
France
USA
Italy
USA
USA, w
Japan
USA
Germany
Australia
CH
Preoperative data
Sex
F
M
F
F
F
F
M
M
M
F
F
F
F
F
F
M
M
M
M
F
F
F
M
M
Age
(y)
52
71
41
23
85
68
27
23
77
37
28
20
19
48
28
51
19
27
27
26
68
45
38
33
Tumor
0(cm)
Massive
9
10
9
5
17
14
8
10
10.5
7
Small
5
6
6
6
8
3
20
5
17
5.5
2
7
Location
Thyroid ?
Thyroid
Thyroid
Thyroid
E-thyroid
Thyroid
Thyroid
Thyroid
Neck
Thyroid
Thyroid
Thyroid
Thyroid
Thyroid
Thyroid
Neck
Thyroid
Thyroid
Thyroid
Neck
NR
Thyroid
St.cl.mast.L
Neck
Path.
Mai
Mai
Mai
Mai
Mai
Mai
Mai
Mai
Mai
Mai
Mai
Mai
Unc
Mai
Mai
Mai
Mai
Mai
Mai
Mai
Mai
Mai
Mai
Mai
Symptom
duration
7
7
5 weeks
6 months
50 years
8 months
12 months
24 months
7 months
3 months
3 months
4 months
4 years
4 months
4 months
5 weeks
3 months
12 months
12 months
Asymptom.
8 months
Immediate
2 weeks
1 month
Imaging
No
No
No
X.I
X
Yes
NR
I
X
US, X,
NB
NR
NR
1. X
X, I
NR
X, Ba,
Tc, IVP
X,Tc
CT
FN, X,
CT
X, I
NR
US, FN
Ba, CT,
US
TcMlbl,
US, X,
CT
Treatment
Surgery
No
?
Yes
Yes
Yes
Yes
Yes
Yes
2x
Yes
Yes
Yes
Yes
Yes
Yes
Yes
2x
Yes
Yes
Yes
Yes
2x
Yes
Yes
Radiation
therapy
(Gy)
No
7
No
Neck,
med
No
Recurr.
No
Yes
No
Yes
Recurr.
No
Yes
46
Yes
No
Recurr
Yes
Yes
No
Recurr.
Yes
No
No
Chemo-
therapy
No
7
No
No
No
No
No
Yes
No
Yes
Yes
Yes
No
Yes
Yes
Cy,C,
B, Ac
No
NR
Cy. A,
E, C
No
No
Vb, C,
B
E. C, B
C, E, B,
adj
Clinical outcome
Local
recur-
rence
Yes
9
Yes
Yes
(sarcoma)
No
Yes
No
Cerv. In
Yes
Yes
Yes
Yes
No
No
Yes
Cerv. In
3x
NR
No
No
Yes
Yes
Yes, 5 cm
No
Distant
metastases
Lu: sarcoma
7
Med, bo, lu
Med, lu, pleu
No
Med, lu, pleu
Lu
No
No
No
Lu
No
No
No
lu
Med, retrocrural
Med, lu, pleu, skin
NR
Lu, meningia
No
Med, lu, pleu
Lu, li, bo
Lu, brain
bo (sarcoma)
Survival
(months)
1
?
1
9
Alive > 7
9
9
10
?
6
14
22
Alive > 8
7
11
Alive > 9
9
NR
2
Alive > 16
8
11
3
well >70
Cause of death
Metastatic tumor
No follow-up
Asphyxia
Sudden, jug. vein
infiltr
Incompl. follow-up
Sudden asphyxia
No follow-up
Local recurrence
No follow-up
Gastric aspiration
Carotid rupture
NR
Incompl. follow-up
No follow-up
NR
Incompl. follow-up
Asphyxia
No follow-up
NR
Incompl follow-up
Sudden asphyxia
Cachexia, cardiac
failure
Cachexia
Probably cured
Remarks
Diagnosis at
autopsy
Quoted by [12]
No autopsy
Autopsy [cf 36]
Pregnant, child
well
Path, descrip-
tion incompl.
Autopsy
Local fistula,
thyroid or.
Pat unnoticed.
thyroid or.
Autopsy [cf 21]
Strumectomy
< 2 years: ben.
hCG mediated
hyperthyr
Adjuvant
chemotherapy
o
So
Chemotherapy is detailed where known; in all patients (except ours), it was administered in the presence of recurrence or of metastases. Note that the case reported by Hajdu in 1967 [8] was later reported again by Jordan in 1988 [36]
Abbreviations: w white; b black; F - female; M male; y - years, e - extra, NR - not reported; St.el.mast L - left sterno-cleido-mastoid muscle; path - pathology, Mai - malignant; unc - uncertain, ben - benign, CT -
computerized tomography; US ultrasound; Tl - 201-T1 thyroid scan; MIBI - 99mTc-methoxyisobutylisonitrile thyroid scan, Tc - 99mTc pertechnetate thyroid scan, I - radioiodide thyroid scan; X - X-ray; Ba - barium swallow; NB -
needle biopsy; FN fine needle aspiration cytology; IVP - intravenous pyelography; In - lymph nodes, cerv - cervical; med - mediastinum, lu - lung; bo - bone; pleu - pleura: h - liver; or - origine; recurr - recurrence; adj - adjuvant;
A adriamycine; Ac actinomycine D; B - blcomycinc; C - cysplatine. Cy - cyclophosphamide; E - vepesid; V - vincnstine, Vb - vinblastine; incompl - incomplete
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with a wide range of cellular differentiation and variable
degrees of maturation. Immature components corre-
sponding most often to germ-cell tumors seem to be of
lesser prognostic significance in infants [6] but represent
a poor prognosis in adults [7].
Since the first report of a neck teratoma by Hess in
1854 [10], about 230 cases have been reported in all ages,
of which 34 were in adults (Tables 1 and 2) [1-3, 11-39].
'Cervical teratoma', the term used nowadays, generally
incorporates lesions arising in the anterior and posterior
triangles of the neck. Cervical teratomas are rare and
represent only 2%-9% of all reported teratoma cases
[40]. The term does not include teratomas of the skull
base or along the cervical spine [7]. The rare event of a
cervical teratoma in an adult should be viewed in a more
general context. By far, most teratomas occur in infants
before the age of one year and are benign, many of them
are present at birth [6, 8]. In adults, teratomas are very
rare; 70% are malignant. Teratomas most often occur in
para-axial or mid-line location from the brain to the
sacral area as well as in the gonads. Table 3 illustrates
that the primary tumor location shows different de-
creasing frequencies in children and adults [7, 9, 45].
The former clinical distinction between a thyroid or
neck origin of a teratoma, - according to: 1) origin of
feeding vessels, 2) direct continuity between tumor and
gland, 3) localization of tumor within the gland, 4) entire
absence of the gland, - has no practical significance
because there are no differences in prognosis or treat-
ment [36]. Moreover, these criteria may be misleading
because it is often impossible to determine the vascular
connections of the tumor. Thyroid parenchyma within
the tumor may represent remaining thyroid from which
the teratoma arose, or well differentiated elements arising
in the teratoma itself, or even thyroid tissue secondarily
invaded by the teratoma.
b) Clinical presentation of cervical teratoma in adults
Out of the 35 reported cases (our case included) of
cervical teratoma in adults, covering various ethnic
origins (Tables 1 and 2), 32.5% were benign and 68.5%
(one uncertain case included) were malignant. The tu-
mor diameter at presentation varied from 3 cm to mas-
7a6/e i. Decreasing frequencies of the locations of a primary teratoma
in infants and children as compared to adults [7, 9,40,48].
Infants and children Adults
Sacrococcygeal region
Ovary
Head and neck
Retroperitoneum
Mediastinum
Brain and spinal cord
Testes
Liver
Abdominal wall, para-umbilical
Scapula (back)
40%
37%
5.5%
5%
4%
3.5%
3%
1%
: 1%
Ovary
Testes
Sacrococcygeal region
Mediastinum
Retroperitoneum
Central nervous system
Liver
Nasal sinuses
Neck
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sive tumors of more than 30 cm. The median symptom
duration before operation was much longer with benign
than with malignant teratomas. Typically, rapid progres-
sion started after a long dormant phase. Metastases and
local recurrences were often sarcomatous.
The median age of the 35 patients was 32 years (range
19-85 years). In 90% of benign teratomas and 58% of
malignant teratomas, the diagnosis was made before the
age of 40 years. The higher the age at diagnosis, the more
likely was the malignant nature of the tumor: the me-
dian age in case of benign disease was 24 years, in case
of malignant disease 35 years. Mochizuki [34] had postu-
lated that cervical teratoma in adults undergoes a rapid
change in biological behavior from benign to malignant
above the age of 20 years, as the youngest malignant
case was seen in a 19-years-old female [28].
c) Imaging
Because most tumors were clinically suspected to be
related to the thyroid, previous imaging of cervical
teratomas was reported as thyroid scintigraphy (99m-Tc
pertechnetate or radioactive iodine), tumor scintigraphy
with 201-T1 or 99mTc-MIBI, ultrasound or CT (Tables 1
and 2). In case of papillary thyroid carcinoma, tumor
scintigraphy with 99mTc-MIBI has been reported pos-
itive [4, 41, 42]. However, it was negative in our patient.
d) Treatment and prognosis
The prognosis of benign teratoma is generally good
(Table 2). But the prognosis of malignant teratoma is
sombre (Table 1): none of the patients with prolonged
follow-up was cured, despite various treatment protocols.
Thus, the maximal survival of the malignant cervical
teratoma reported to date was 22 months (median nine
months, average eight months, Table 1). External radio-
therapy since the 1950's and, since the late 1970's, che-
motherapy, relying today mostly on cisplatin-containing
regimens [43], have been administered after surgical ex-
cision. These treatments were always applied late in the
course of the disease, when there were large tumor bur-
dens, and their effect was only palliative. For other extra-
gonadal teratocarcinomas such as those of the anterior
mediastinum, the prognosis is inferior to the one of
testicular teratocarcinomas with longterm survivals of
40%-50%, where as such tumors arising from the ova-
ries (non-dysgerminomatous germ-cell tumors) have an
excellent survival after intensive chemotherapy, compa-
rably to testicular teratocarcinoma [46,47].
In contrast, our patient with a cervical malignant
teratoma with components of germ cell and of mesen-
chymal tumors was given BEP-chemotherapy [5] with
adjuvant intent in the postoperative course based on
clinical experience with germ cell tumors in general. In
a British study of clinical stage I patients with non-
seminomatous germ cell tumors of the testicle, the pre-
study relapse rate was 30%. This was reduced to 5% by a
treatment policy of two courses of adjuvant bleomycin,
etoposide and cisplatin (BEP). This 5% relapse rate com-
pared favorably with that of 18.5% in clinical stage I
patients treated by surgery alone [44]. Therefore, ad-
juvant BEP-chemotherapy in the postoperative course
in general is effective in preventing relapse in patients
with testicular germ cell tumors in general and, hope-
fully with malignant teratoma (with germ-cell compo-
nents).
As is the case with chemotherapy, prognosic factors
for malignant teratoma are deduced from those of germ
cell tumors in general. For testicular germ-cell cancer,
the extent of disease and serum tumor-marker concen-
trations were identified as independent predictors of
prognosis, and previously untreated patients with meta-
static disease were subdivided into good-risk and poor-
risk groups [50, 51]. This staging system was developed
because of the high cure rate and substantial toxicity
of combination chemotherapy and a need to identify
patients more likely ('good-risk') and less likely ('poor-
risk') to be cured by standard chemotherapy. In another
British multicenter study on non-seminomatous germ-
cell tumors of the testicle, the only significant independ-
ent prognostic factors were based on histology and
lymphatic invasion [48]. The relapse rates ranged from
six out of 50 cases (12%) in teratocarcinoma patients
without lymphatic invasion to seven out of nine cases
(78%) of embryonal carcinoma patients with lymphatic
invasion [49]. By analogy, our patient belonged to the
high-risk category for relapse because of embryonal
components in the primary tumor with minimal lym-
phatic invasion and because of the bone metastasis
(excised chondrosarcoma in the 10th left rib). This metas-
tasis was already present at the time of the neck oper-
ation, albeit not yet pathologically proven because of the
patient's initial refusal of rib surgery. Nevertheless, the
patient has remained tumor free for nearly six years
after neck surgery. The en bloc surgical removal of the
tumor without rupture of the capsule, followed by BEP-
chemotherapy and complete removal of the solitary
metastasis, appear to have eradicated the tumor. Five-
year progression-free survival rates between 66% and
78% according to histological findings of postchemo-
therapy resections of residual masses from metastatic
non-seminomatous testicular germ-cell tumors retro-
spectively confirm the Tightness of our therapeutic atti-
tude. It especially confirms how essential the primary
en bloc surgical removal of the tumor is [46]. This is
amplified since, as also shown in mediastinal non-semi-
nomatous germ-cell tumors, only patients who achieve
disease-free status after cisplatin-based combination
chemotherapy are likely to be cured [47].
Of the previously reported patients in the literature
(Tables 1 and 2), [1-3, 11-39], our patient was the only
one, where there was a decision to treat with adjuvant
chemotherapy. This meant that there was no delay in the
patient receiving chemotherapy for what turned out to
be metastatic disease. Compared to the sombre progno-
sis of cervical malignant teratoma in adults (Table 1), the
good clinical five-year outcome of our patient suggests
1021
that the use of 'adjuvant' BEP-chemotherapy, - as classi-
cally used with germ cell tumors, - immediately after
the neck resection and independently of the pathologic
nature of the rib tumor, was appropriate. We suggest
that a policy of adjuvant chemotherapy should be exam-
ined in other non-gonadal malignant teratoma patients
in the future, in order to gain prospective evidence of its
possible beneficial influence on prognosis.
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